Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Individualized prediction of clinical progression to dementia using plasma biomarkers in non-demented elderly.
Honey MIJ, van Maurik IS, van Harten AC, Gouda M, van Leeuwenstijn M, Mank A, Trieu C, Bouteloup V, Chêne G, Pellegrin I, Dufouil C, Doecke JD, Fowler CJ, Masters CL, Pijnenburg Y, Wilson D, van der Flier WM, Teunissen CE, Verberk IMW. Honey MIJ, et al. Among authors: van leeuwenstijn m. Alzheimers Res Ther. 2025 Dec 3. doi: 10.1186/s13195-025-01925-1. Online ahead of print. Alzheimers Res Ther. 2025. PMID: 41339948 Free article.
Longitudinal Blood-Based Biomarkers and Clinical Progression in Subjective Cognitive Decline.
Trieu C, van Harten AC, van Leeuwenstijn MSSA, Schlüter LM, Boonkamp L, Aladdin A, Sikkes SAM, van de Giessen E, Verberk IMW, Teunissen CE, van der Flier WM. Trieu C, et al. Among authors: van leeuwenstijn mssa. JAMA Netw Open. 2025 Dec 1;8(12):e2545862. doi: 10.1001/jamanetworkopen.2025.45862. JAMA Netw Open. 2025. PMID: 41335440 Free PMC article.
Evidence-based standardized sample handling protocol for accurate blood-based Alzheimer's disease biomarker measurement: Results and consensus of the Global Biomarker Standardization Consortium.
Verberk IMW, Gouda M, Antwi-Berko D, van Leeuwenstijn M, Bongers B, Houtkamp IM, van der Flier WM, Janelidze S, Hansson O, Bastard NL, Vandijck M, Hunter J, Honigberg L, Kirmess KM, Verghese PB, Blennow K, Zetterberg H, Meyers EA, Edelmayer RM, Teunissen C. Verberk IMW, et al. Among authors: van leeuwenstijn m. Alzheimers Dement. 2025 Oct;21(10):e70752. doi: 10.1002/alz.70752. Alzheimers Dement. 2025. PMID: 41025225 Free PMC article.
Longitudinal associations between amyloid and symptoms of depression and anxiety in subjective cognitive decline: the impact of personality characteristics.
Trieu C, van Leeuwenstijn MSSA, Schlüter LM, Ebenau JL, Verberk IMW, Sikkes SAM, Verfaillie SCJ, van de Giessen E, Teunissen CE, van der Flier WM, van Harten AC. Trieu C, et al. Among authors: van leeuwenstijn mssa. Front Psychiatry. 2025 Jun 10;16:1572174. doi: 10.3389/fpsyt.2025.1572174. eCollection 2025. Front Psychiatry. 2025. PMID: 40557139 Free PMC article.
Cognitive and Functional Change Over Time in Cognitively Healthy Individuals According to Alzheimer Disease Biomarker-Defined Subgroups.
Dubbelman MA, Hendriksen HMA, Harrison JE, Vijverberg EGB, Prins ND, Kroeze LA, Ottenhoff L, Van Leeuwenstijn MMSSA, Verberk IMW, Teunissen CE, van de Giessen EM, Van Harten AC, Van Der Flier WM, Sikkes SAM. Dubbelman MA, et al. Among authors: van leeuwenstijn mmssa. Neurology. 2024 Jan 23;102(2):e207978. doi: 10.1212/WNL.0000000000207978. Epub 2023 Dec 26. Neurology. 2024. PMID: 38165338 Free PMC article.
Changes in self- and study partner-perceived cognitive functioning in relation to amyloid status and future clinical progression: Findings from the SCIENCe project.
Dubbelman MA, Sikkes SAM, Ebenau JL, van Leeuwenstijn MSSA, Kroeze LA, Trieu C, van Berckel BNM, Teunissen CE, van Harten AC, van der Flier WM. Dubbelman MA, et al. Among authors: van leeuwenstijn mssa. Alzheimers Dement. 2023 Jul;19(7):2933-2942. doi: 10.1002/alz.12931. Epub 2023 Jan 15. Alzheimers Dement. 2023. PMID: 36642977
Optimizing cCOG, a Web-based tool, to detect dementia with Lewy Bodies.
van Gils AM, van de Beek M, van Unnik AAJM, Tolonen A, Handgraaf D, van Leeuwenstijn M, Lötjönen J, van der Flier WM, Lemstra A, Rhodius-Meester HFM. van Gils AM, et al. Among authors: van leeuwenstijn m. Alzheimers Dement (Amst). 2022 Dec 22;14(1):e12379. doi: 10.1002/dad2.12379. eCollection 2022. Alzheimers Dement (Amst). 2022. PMID: 36569383 Free PMC article.
Cerebral blood flow, amyloid burden, and cognition in cognitively normal individuals.
Ebenau JL, Visser D, Verfaillie SCJ, Timmers T, van Leeuwenstijn MSSA, Kate MT, Windhorst AD, Barkhof F, Scheltens P, Prins ND, Boellaard R, van der Flier WM, van Berckel BNM. Ebenau JL, et al. Among authors: van leeuwenstijn mssa. Eur J Nucl Med Mol Imaging. 2023 Jan;50(2):410-422. doi: 10.1007/s00259-022-05958-8. Epub 2022 Sep 8. Eur J Nucl Med Mol Imaging. 2023. PMID: 36071221 Free PMC article.
Longitudinal change in ATN biomarkers in cognitively normal individuals.
Ebenau JL, Visser D, Kroeze LA, van Leeuwenstijn MSSA, van Harten AC, Windhorst AD, Golla SVS, Boellaard R, Scheltens P, Barkhof F, van Berckel BNM, van der Flier WM. Ebenau JL, et al. Among authors: van leeuwenstijn mssa. Alzheimers Res Ther. 2022 Sep 3;14(1):124. doi: 10.1186/s13195-022-01069-6. Alzheimers Res Ther. 2022. PMID: 36057616 Free PMC article.
18 results